RECOMBINATE 500 IU

Țară: Israel

Limbă: engleză

Sursă: Ministry of Health

Ingredient activ:

COAGULATION FACTOR VIII RECOMBINANT 500 IU/VIAL

Disponibil de la:

TEVA MEDICAL MARKETING LTD.

Codul ATC:

B02BD05

Forma farmaceutică:

POWDER FOR SOLUTION FOR INJECTION

Calea de administrare:

I.V

Produs de:

BAXTER S.A., BELGIUM

Grupul Terapeutică:

COAGULATION FACTOR VII

Indicații terapeutice:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Data de autorizare:

2010-07-01